SEC Filings

< Back

SEC Filing Details

Document Details

Form
D
Filing Date
Jan 22, 2024
Document Date
Jan 22, 2024
Form Description
Notice of Exempt Offering of Securities
Filing Group
Other
Company
Polypid
Issuer
PolyPid Ltd.

Technology

PolyPid’s PLEX targeted drug delivery platform enables localized, controlled, continuous release of medication over prolonged periods of time for better patient outcomes.

Read More >
D-PLEX100

D-PLEX100

Provides safe and effective local antibiotic protection against SSI (surgical Site Infection) at the needed tissues or organs by administration during surgical procedures.

Read More >
D-PLEX1000

D-PLEX1000

Comprised of antibiotic eluting ß tri-calcium phosphate (ßTCP) granules, designed for bone related infections applications.

Read More >